These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23960315)

  • 41. Vascular Anomalies: A Pediatric Surgeon's Perspective.
    Gupta A; Verma A; Dhua A; Bhatnagar V
    Indian J Pediatr; 2017 Aug; 84(8):612-617. PubMed ID: 28466404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sclerotherapy with Adjunctive Stasis of Efflux (STASE) in Venous Malformations: Techniques and Strategies.
    Legiehn GM
    Tech Vasc Interv Radiol; 2019 Dec; 22(4):100630. PubMed ID: 31864535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of lymphatic malformations in oral and maxillofacial regions: the rationale according to the new classification].
    Zheng JW; Qin ZP; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):553-6. PubMed ID: 16400476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complications of sclerotherapy for 75 head and neck venous malformations.
    Castrén E; Aronniemi J; Klockars T; Pekkola J; Lappalainen K; Vuola P; Salminen P; Pitkäranta A
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1027-36. PubMed ID: 25731642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical excision as primary treatment modality for extensive cervicofacial lymphatic malformations in children.
    Bajaj Y; Hewitt R; Ifeacho S; Hartley BE
    Int J Pediatr Otorhinolaryngol; 2011 May; 75(5):673-7. PubMed ID: 21419500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up.
    James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM
    J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center.
    Ali S; Weiss CR; Sinha A; Eng J; Mitchell SE
    Phlebology; 2016 Oct; 31(9):603-9. PubMed ID: 27009607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.
    Muir T; Kirsten M; Fourie P; Dippenaar N; Ionescu GO
    Pediatr Surg Int; 2004 Jan; 19(12):766-73. PubMed ID: 14740248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and Safety of Sclerotherapy for Treatment of Low-Flow Vascular Malformations of the Oropharyngeal Region.
    Bourgouin P; Thomas-Chaussé F; Gilbert P; Giroux MF; Périgny S; Guertin L; Dubois J; Soulez G
    J Vasc Interv Radiol; 2018 Jun; 29(6):809-815. PubMed ID: 29628299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
    Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of high-flow vascular malformations in the head and neck with arterial ligation followed by sclerotherapy.
    Chen MT; Horng SY; Yeong EK; Pan QD
    Ann Plast Surg; 1996 Feb; 36(2):147-53. PubMed ID: 8919377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases.
    Min HG; Kim SG; Oh JS; You JS
    J Korean Assoc Oral Maxillofac Surg; 2015 Dec; 41(6):322-6. PubMed ID: 26734559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intralesional radiofrequency in venous malformations.
    Garg S; Kumar S; Singh YB
    Br J Oral Maxillofac Surg; 2015 Mar; 53(3):213-6. PubMed ID: 25554592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations.
    Lee HJ; Kim TW; Kim JM; Kim GW; Ko HC; Kim BS; Kim MB; Kim HS
    Int J Dermatol; 2017 Nov; 56(11):1186-1191. PubMed ID: 28869282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sclerotherapy complications of peripheral venous malformations.
    Aronniemi J; Castrén E; Lappalainen K; Vuola P; Salminen P; Pitkäranta A; Pekkola J
    Phlebology; 2016 Dec; 31(10):712-722. PubMed ID: 26494223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An institution-wide algorithm for direct-stick embolization of peripheral venous malformations.
    Nassiri N; Huntress LA; Simon M; Murphy S
    J Vasc Surg Venous Lymphat Disord; 2018 May; 6(3):351-357. PubMed ID: 29396158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interdisciplinary concept for classification and treatment of vascular anomalies in the head and neck].
    Ernemann U; Hoffmann J; Breuninger H; Reinert S; Skalej M
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):402-9. PubMed ID: 12447652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.
    Oomen KP; Paramasivam S; Waner M; Niimi Y; Fifi JT; Berenstein A; O TM
    Laryngoscope; 2016 Jan; 126(1):205-11. PubMed ID: 25970858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined surgery and sclerotherapy for massive venous malformations of the tongue].
    Huang X; Zou H; Guo X; Zhao Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jan; 32(1):14-7. PubMed ID: 27197473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life after endovascular sclerotherapy of low-flow venous malformations: the efficacy of polidocanol compared with ethanol.
    Weitz-Tuoretmaa A; Keski-Nisula L; Rautio R; Laranne J
    Acta Radiol; 2018 Aug; 59(8):946-952. PubMed ID: 29124942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.